NCT00540800View on ClinicalTrials.gov

BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

139

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

September 30, 2009

Study Completion Date

December 31, 2009

Conditions

Breast Cancer

Interventions

DRUG

docetaxel

given in combination with epirubicin or capecitabine

DRUG

epirubicin

for patients with locally advanced breast cancer, or metastatic breast cancer not previously treated with anthracyclines

DRUG

capecitabine

for metastatic breast cancer patients previously treated with anthracyclines

Trial Locations (3)

80131

Istituto Nazionale dei Tumori , Divisione di Oncologia Medica B, Napoli

Istituto Nazionale dei Tumori, Divisione di Oncologia Medica C, Napoli

Unknown

Ospedale S. Luca ASL SA 3, Vallo della Lucania

All Listed Sponsors

lead

National Cancer Institute, Naples

OTHER

NCT00540800 - BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer | Biotech Hunter | Biotech Hunter